Fatal Neuroinvasive Astrovirus VA1 Encephalitis in a Child With High‐Risk B‐ALL Receiving Blinatumomab
Abstract
O.L. is a named inventor on patents held by Boston Children's Hospital related to vaccine adjuvants and antigens as well as human in vitro systems that model the safety and immunogenicity of vaccines and immunotherapeutics. O.L.’s laboratory receives sponsored research support from, and he is a consultant to, GlaxoSmithKline (GSK). He is a co-founder of ARMR Sciences. Relevant sequencing files will be available by 2027-02-01 or on publication (whichever is sooner) in the NCBI Sequence Read Archive (SubmissionID: SUB15939320, BioProject ID: PRJNA1404327).
// Source
Authors: Alaric W. D’Souza, Pietro Miozzo, Molly Wilson-Murphy, Andrew E. Place, Sudeb Dalai, Steve Miller, Ofer Levy, Seth Rakoff-Nahoum
Institutions: Harvard University, University of California, San Francisco, Stanford University, Broad Institute, Boston Children's Hospital, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Museum, Biogen (United States)